EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-24 00:00 |
기타경영사항(자율공시)([국책과제 선정]다가 코로나19 예방 mRNA백신 개발-신변종 감염병대응 mRNA백신 임상지원 (2차년도))
|
Korean | 7.2 KB | ||
| 2023-04-13 00:00 |
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 남아프리카공화국 부스터 임상 제 1/2a상 시험 자진 취하)
|
Korean | 13.6 KB | ||
| 2023-04-07 00:00 |
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 호주 부스터 임상 제 1/2a상 시험 계획 변경 승인)
|
Korean | 12.9 KB | ||
| 2023-04-07 00:00 |
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 국내 임상 제 1/2a상 시험 조기 종료)
|
Korean | 14.0 KB | ||
| 2023-04-06 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 84.9 KB | ||
| 2023-03-29 00:00 |
투자판단관련주요경영사항(아이진 mRNA 기반 코로나-19 예방백신 (EG-COVID) 호주 부스터 임상 제 1/2a상 시험 계획 변경 승인 신…
|
Korean | 11.2 KB | ||
| 2023-03-23 00:00 |
정기주주총회결과
|
Korean | 19.3 KB | ||
| 2023-03-15 00:00 |
사업보고서 (2022.12)
|
Korean | 1.4 MB | ||
| 2023-03-15 00:00 |
감사보고서제출
|
Korean | 25.2 KB | ||
| 2023-03-15 00:00 |
[기재정정]감사보고서제출
|
Korean | 29.6 KB | ||
| 2023-03-15 00:00 |
[기재정정]감사보고서제출
|
Korean | 28.6 KB | ||
| 2023-03-08 00:00 |
주주총회소집공고
|
Korean | 169.6 KB | ||
| 2023-02-28 00:00 |
의결권대리행사권유참고서류
|
Korean | 135.0 KB | ||
| 2023-02-24 00:00 |
주주총회소집결의
|
Korean | 9.3 KB | ||
| 2023-02-08 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
